Primary central nervous system lymphoblastic B cell lymphoma located at cerebellum in a child: A case report and literature review.

IF 1.9 4区 医学 Q2 PEDIATRICS
Pediatric Investigation Pub Date : 2021-12-13 eCollection Date: 2021-12-01 DOI:10.1002/ped4.12303
Xueliang Yang, Yanlong Duan, Chunju Zhou, Ling Jin, Ningning Zhang, Shuang Huang, Meng Zhang, Jing Yang, Yonghong Zhang
{"title":"Primary central nervous system lymphoblastic B cell lymphoma located at cerebellum in a child: A case report and literature review.","authors":"Xueliang Yang, Yanlong Duan, Chunju Zhou, Ling Jin, Ningning Zhang, Shuang Huang, Meng Zhang, Jing Yang, Yonghong Zhang","doi":"10.1002/ped4.12303","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Primary central nervous system lymphoma (PCNSL) is extremely rare in pediatric population. We reported a case of PCNSL in a 3-year-old girl and reviewed the literature in the past three decades.</p><p><strong>Case presentation: </strong>A 3-year-old girl presented with gait disturbance. A contrast-enhanced magnetic resonance image of the brain showed a solitary bulky mass in the left cerebellar hemisphere, hydrocephalus and cerebellar tonsillar hernia. Surgical resection was performed and the patient was diagnosed with primary central nervous system lymphoblastic B cell lymphoma. Then the patient received regular chemotherapy, including 6 cycles of chemotherapy containing high-dose methotrexate (HD-MTX). The patient remains alive 15 months after the diagnosis with no evidence of active disease, but suffered twice chronic subdural hematoma, which was treated by burr hole drainage.</p><p><strong>Conclusion: </strong>Lymphoblastic B cell lymphoma is a rare histologic subtype of pediatric PCNSL. Chemotherapy containing HD-MTX remains the most effective treatment. The patient should avoid head impact after surgical resection of the tumor to prevent chronic subdural hematoma.</p>","PeriodicalId":19992,"journal":{"name":"Pediatric Investigation","volume":"5 4","pages":"318-322"},"PeriodicalIF":1.9000,"publicationDate":"2021-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4e/40/PED4-5-318.PMC8666934.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ped4.12303","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/12/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Primary central nervous system lymphoma (PCNSL) is extremely rare in pediatric population. We reported a case of PCNSL in a 3-year-old girl and reviewed the literature in the past three decades.

Case presentation: A 3-year-old girl presented with gait disturbance. A contrast-enhanced magnetic resonance image of the brain showed a solitary bulky mass in the left cerebellar hemisphere, hydrocephalus and cerebellar tonsillar hernia. Surgical resection was performed and the patient was diagnosed with primary central nervous system lymphoblastic B cell lymphoma. Then the patient received regular chemotherapy, including 6 cycles of chemotherapy containing high-dose methotrexate (HD-MTX). The patient remains alive 15 months after the diagnosis with no evidence of active disease, but suffered twice chronic subdural hematoma, which was treated by burr hole drainage.

Conclusion: Lymphoblastic B cell lymphoma is a rare histologic subtype of pediatric PCNSL. Chemotherapy containing HD-MTX remains the most effective treatment. The patient should avoid head impact after surgical resection of the tumor to prevent chronic subdural hematoma.

Abstract Image

Abstract Image

Abstract Image

位于儿童小脑的原发性中枢神经系统淋巴母细胞 B 细胞淋巴瘤:病例报告和文献综述。
简介原发性中枢神经系统淋巴瘤(PCNSL)在儿童中极为罕见。我们报告了一例 3 岁女孩的 PCNSL 病例,并回顾了过去 30 年的文献:一名 3 岁女童出现步态障碍。脑部对比增强磁共振图像显示,左侧小脑半球有一单发肿块,并伴有脑积水和小脑扁桃体疝。手术切除后,患者被诊断为原发性中枢神经系统淋巴母细胞 B 细胞淋巴瘤。随后,患者接受了常规化疗,包括 6 个周期的大剂量甲氨蝶呤(HD-MTX)化疗。确诊 15 个月后,患者仍然存活,没有活动性疾病的迹象,但出现了两次慢性硬膜下血肿,通过毛细孔引流术进行了治疗:淋巴母细胞B细胞淋巴瘤是小儿PCNSL的一种罕见组织学亚型。含有HD-MTX的化疗仍是最有效的治疗方法。手术切除肿瘤后,患者应避免头部撞击,以防出现慢性硬膜下血肿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pediatric Investigation
Pediatric Investigation Medicine-Pediatrics, Perinatology and Child Health
CiteScore
3.30
自引率
0.00%
发文量
176
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信